Features of immunophenotype of pancreatic ductal adenocarcinoma

Aim. To determine features of immunophenotype of pancreatic ductal adenocarcinoma. Methods and results. At the immunohistochemical research of biopsy and postoperative material of 120 patients with pancreatic ductal adenocarcinoma the expression levels of diagnostic markers of ductal-genesis canc...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Zaporožskij Medicinskij Žurnal
المؤلف الرئيسي:	A. V. Evseyev
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Zaporizhzhia State Medical and Pharmaceutical University 2014-12-01
الموضوعات:	Pancreatic Cancer Immunohistochemistry
الوصول للمادة أونلاين:	http://zmj.zsmu.edu.ua/article/view/35867/32109

مواد مشابهة

Quantitative indexes of stromal markers expression in the pancreatic ductal adenocarcinoma and chronic pancreatitis
حسب: V. A. Tumanskiy, وآخرون
منشور في: (2015-08-01)

Comparative estimation of ErbB family growth receptors, Ki-67 and E-cadherin expression in pancreatic ductal adenocarcinoma cells
حسب: V. A. Tumanskiy, وآخرون
منشور في: (2014-12-01)

Pathomorphological description of proliferation and apoptosis processes in pancreatic intraepithelial neoplasia in the pancreatic ductal adenocarcinoma and chronic pancreatitis
حسب: V. A. Tumanskiy, وآخرون
منشور في: (2014-08-01)

Immunohistochemical Evaluation of the Tumor Immune Microenvironment in Pancreatic Ductal Adenocarcinoma
حسب: Gelu Mihai Breaza, وآخرون
منشور في: (2025-03-01)

KRT81 and HNF1A expression in pancreatic ductal adenocarcinoma: investigation of predictive and prognostic value of immunohistochemistry‐based subtyping
حسب: Jia Rao, وآخرون
منشور في: (2024-05-01)

Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
حسب: Gitika Thakur, وآخرون
منشور في: (2021-02-01)

Administration of aspirin and risk of pancreatic ductal adenocarcinoma
حسب: Arooba Noor Abbasi, وآخرون
منشور في: (2024-12-01)

Pancreatic Ductal Adenocarcinoma: Epidemiology and Risk Factors
حسب: Jun Ushio, وآخرون
منشور في: (2021-03-01)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
حسب: Raffaele Pezzilli, وآخرون
منشور في: (2011-07-01)

Galectin-8 Immunohistochemical Profile in Pancreatic Ductal Adenocarcinoma: Emerging Evidence for Its Prognostic Role
حسب: Andreea Rusu, وآخرون
منشور في: (2023-10-01)

Phosphomannose Isomerase High Expression Associated with Better Prognosis in Pancreatic Ductal Adenocarcinoma
حسب: Alipour Z, وآخرون
منشور في: (2021-09-01)

Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
حسب: Jannat Pervin, وآخرون
منشور في: (2023-10-01)

Lack of association between SLFN11 expression and treatment efficacy or survival outcomes in patients with pancreatic ductal adenocarcinoma
حسب: Takeaki Nakamura, وآخرون
منشور في: (2025-05-01)

Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
حسب: Flis Vojko, وآخرون
منشور في: (2016-09-01)

Unusual Case of Pancreatic Adenocarcinoma with Bladder Metastasis
حسب: Giorgia Arcovito, وآخرون
منشور في: (2020-12-01)

Ferroptosis: New Strategies and Ideas for the Treatment of Pancreatic Ductal Adenocarcinoma
حسب: Chengru Yang, وآخرون
منشور في: (2024-01-01)

The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies
حسب: Marwa Elsayed, وآخرون
منشور في: (2021-04-01)

Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
حسب: Rita Rebelo, وآخرون
منشور في: (2021-03-01)

Prognostic Value of Transfer Learning Based Features in Resectable Pancreatic Ductal Adenocarcinoma
حسب: Yucheng Zhang, وآخرون
منشور في: (2020-10-01)

Epigenetic Landscape of DNA Methylation in Pancreatic Ductal Adenocarcinoma
حسب: Peiyi Liu, وآخرون
منشور في: (2024-11-01)

Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
حسب: Zoe C. Schmiechen, وآخرون
منشور في: (2021-01-01)

Targeting Advanced Pancreatic Ductal Adenocarcinoma: A Practical Overview
حسب: Chiara Citterio, وآخرون
منشور في: (2025-07-01)

Differentiation of pancreatic ductal adenocarcinoma and chronic pancreatitis using graph neural networks on histopathology and collagen fiber features
حسب: Bin Li, وآخرون
منشور في: (2022-01-01)

The Role of Resolvin D1 in the Differential Diagnosis of Pancreatic Ductal Adenocarcinoma and Acute Pancreatitis: A Case-Control Study
حسب: Yasemin Pekmezci, وآخرون
منشور في: (2025-01-01)

MORPHOLOGICAL AND EXPRESSION FEATURES OF DUCTAL PANCREATIC ADENOCARCINOMA
حسب: Yu. Yu. Rakina, وآخرون
منشور في: (2017-09-01)

THE SUBTYPES OF PANCREATIC DUCTAL ADENOCARCINOMAS
حسب: Apeksha Kakkar, وآخرون
منشور في: (2016-12-01)

The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma
حسب: Sona Ciernikova, وآخرون
منشور في: (2020-12-01)

Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma
حسب: Hiromitsu Hayashi, وآخرون
منشور في: (2021-07-01)

Combination immunohistochemistry for CK5/6, p63, GATA6, and HNF4a predicts clinical outcome in treatment-naïve pancreatic ductal adenocarcinoma
حسب: Takahiro Shibayama, وآخرون
منشور في: (2024-07-01)

An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma
حسب: Amy Makler, وآخرون
منشور في: (2022-10-01)

Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinoma
حسب: Chelsae R. Watters, وآخرون
منشور في: (2025-03-01)

Diffuse pancreatic parenchymal atrophy, an imaging finding predictive of the development of pancreatic ductal adenocarcinoma: A case–control study
حسب: Akinobu Koiwai, وآخرون
منشور في: (2023-06-01)

Clinical Implications of Mismatch Repair Deficiency in Pancreatic Ductal Adenocarcinoma
حسب: Zachary Kaplan, وآخرون
منشور في: (2025-05-01)

Inflammatory Cytokines and Radiotherapy in Pancreatic Ductal Adenocarcinoma
حسب: Sylvia S. W. Ng, وآخرون
منشور في: (2022-12-01)

Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments
حسب: Doaa Bugazia, وآخرون
منشور في: (2024-07-01)

Immunohistochemical characteristics of epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma
حسب: M. A. Shyshkin, وآخرون
منشور في: (2024-04-01)

Syndecans and Pancreatic Ductal Adenocarcinoma
حسب: Nausika Betriu, وآخرون
منشور في: (2021-02-01)

Nanocarriers for Combination Therapy in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review
حسب: Iris Pontón, وآخرون
منشور في: (2025-07-01)

Consensus statement on the use of systemic therapies in pancreatic ductal adenocarcinoma in Asia
حسب: D.-Y. Oh, وآخرون
منشور في: (2025-06-01)

Pancreatic Carcinoma Metastatic to the Gingiva
حسب: Arijan Zubović, وآخرون
منشور في: (2021-01-01)